Searchicon: search

A Lyme vaccine like
no other

Product Description

Indications: Shown to be effective for vaccination of healthy dogs 8 weeks of age or older against Borrelia burgdorferi. Duration of immunity is at least 1 year. Nobivac® Lyme has also been shown to be effective against subclinical arthritis caused by Borrelia burgdorferi.1

  • Subcutaneous injection
  • Two 1 mL doses given 2 to 4 weeks apart
  • Duration of immunity is at least 1 year
  • Available in a 25 x 1 mL dose presentation
product Label

Nobivac® Lyme at a glance

Subclinical protection

The only vaccine labeled effective against subclinical arthritis and other signs of Lyme disease.1,2

Unique killing power

The only vaccine proven to trigger borreliacidal antibodies that kill viable B burgdorferi expressing OspA and OspC variants.1-3

Get to Know Nobivac® Lyme

Stop Canine Lyme Disease

Nobivac® Lyme vs. the competition

Efficacy tick challenge study1

Finally, a Lyme vaccination effective against subclinical arthritis.1

The borreliacidal antibodies induced by Nobivac® Lyme were shown to be effective against B burgdorferi in both the tick and dog*

*The tick challenge study was a placebo-controlled trial involving thirty, 8-week-old puppies. Dogs were challenged 3 weeks after second vaccination.

Full vs. partial protection

More coverage against more variants2

There are more than 30 different variations of OspC in the Northeastern United States.4 Those variants are represented as different colors in the graphics below.

VANGUARD® crLyme recognizes 7 OspC variants of B burgdorferi and tags them for the immune system to kill later.3

Nobivac® Lyme targets a conserved region of the OspC antigen present in variants of OspC.1 Only Nobivac® Lyme targets and kills variants that express the highly conserved region.1,3

The difference in protection

Nobivac® Lyme vs VANGUARD® crLyme

WATCH THE VIDEO

A safe and trusted solution

Safely administered in over 11 million dogs since 2009.

Safety study2

  • Proven safe and well tolerated in a field safety trial of more than 600 dogs
  • 99.3% reaction-free
  • Since 2009, Nobivac® Lyme has been safely administered to over 4 million dogs

Dosage Information

Indications: Shown to be effective for vaccination of healthy dogs 8 weeks of age or older against Borrelia burgdorferi. Duration of immunity is at least 1 year. Nobivac® Lyme has also been shown to be effective against subclinical arthritis caused by Borrelia burgdorferi.1

  • Subcutaneous injection
  • Two 1 mL doses given 2 to 4 weeks apart
  • Duration of immunity is at least 1 year
  • Available in a 25 x 1 mL dose presentation
Product label

Bovilis Vista SQ Chart

Learn more

Recommendations
for administration

Indications: Shown to be effective for vaccination of healthy dogs 8 weeks of age or older against Borrelia burgdorferi. Duration of immunity is at least 1 year. Nobivac® Lyme has also been shown to be effective against subclinical arthritis caused by Borrelia burgdorferi.1

  • Store at 35 °F – 46 °F
  • Bring to room temperature before use
  • Mix well
  • Administer in the interscapular space
  • Deliver the vaccine with a 22-gauge sterile needle
watch the video

Bovilis Vista SQ Chart

Learn more

The Nobivac Guarantee

Merck Animal Health stands behind the entire line of Nobivac® vaccines.

LEARN MORE

References

  1. La Fleur RL, Dant JC, Wasmoen TL, et al. Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease. Clin Vaccine lmmunol. 2009;16:253-259. doi:10.1128/CVI.00373-08
  2. Data on file. Merck Animal Health.
  3. Dant JC, La Fleur RL, Callister SM, Stahl M, Sutton D, Tarpey I. Ability of antibodies induced by canine Lyme disease vaccines to kill viable spirochetes. Poster presented at: The ISCAID Symposium; October 16-19, 2016; Bristol, UK.
  4. Rhodes, et al. Identification of B. burgdorferi OspC genotypes in canine tissue following tick infection: Implications for Lyme disease vaccine and diagnostic assay design. Vet J. 2013
  5. Nobivac Lyme. Product Label. Merck Animal Health.  Accessed September 12, 2023. https://merckusa.cvpservice.com/product/basic/view/1047295
  6. RECOMBITEK© Lyme. Product label. Boehringer lngelheim Animal Health; 2017.
  7. TruCan™ Lyme. Product Label. Elanco; 2021.
  8. VANGUARD© crLyme. Product Label. Zoetis, lnc.;2017.